In RA study IV, the ACR 20 response of patients treated with Humira plus standard of care was statistically significantly better than patients treated with placebo plus standard of care (p < 0.001).
RA uuringus IV oli Humira’ t ja tavaravi saanud patsientide ACR 20 vastus statistiliselt oluliselt parem kui patsientidel, kes said platseebot koos tavaraviga (p < 0, 001).